Biocon Limited has informed the Exchange about Rumour Verification - Regulation 30(11)

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.8%1-day move

₹381.85

prior close

₹384.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.7-0.7-0.5+0.1-0.8+2.7+5.7+9.0+9.5+11.8+13.1+6.8+6.3—

Up moveDown movePending

AI summary

The BSE and NSE asked Biocon to clarify a news report claiming Executive Chairperson Kiran Mazumdar-Shaw was choosing her niece Claire Mazumdar as her successor, which triggered unusual price movement in the scrip on May 6, 2026. The company has firmly denied the rumor, stating that Kiran Mazumdar-Shaw continues in her role as Executive Chairperson with no impending management changes. Biocon further stated there is no material ownership succession information requiring disclosure. The company emphasized it is led by CEO & Managing Director Shreehas Tambe and remains committed to governance standards.

Likely market impact

The clarification confirms no leadership transition is underway, which should reassure investors concerned by the false succession report. No material information has been withheld from the market.